- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/52 - Isomerases (5)
Patent holdings for IPC class A61K 38/52
Total number of patents in this class: 121
10-year publication summary
|
14
|
16
|
12
|
11
|
9
|
14
|
8
|
12
|
6
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Modernatx, Inc. | 1282 |
10 |
| Seattle Children's Research Institute | 17 |
8 |
| Vitamerica UG (haftungsbeschrankt) | 8 |
7 |
| The Regents of the University of California | 20590 |
5 |
| Rowan University | 194 |
4 |
| Translate bio, Inc. | 413 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6615 |
3 |
| DSM IP Assets B.V. | 5422 |
3 |
| Baylor College of Medicine | 1000 |
3 |
| Poseida Therapeutics, Inc. | 170 |
3 |
| Allogene Therapeutics, Inc. | 162 |
3 |
| President and Fellows of Harvard College | 6060 |
2 |
| The Broad Institute, Inc. | 1948 |
2 |
| Rijksuniversiteit Groningen | 311 |
2 |
| SCIOTEC Diagnostic Technologies GmbH | 4 |
2 |
| Spark Therapeutics, Inc. | 178 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2980 |
2 |
| University of Delaware | 373 |
2 |
| Vitamerica UG | 2 |
2 |
| Obsidian Therapeutics, Inc. | 76 |
2 |
| Other owners | 50 |